Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Maxygen “Confident” About MAXY-4 Patents – Astellas, Too

Sep 19 2008

• By Randall Osborne

Related Content

Maxygen Gets $90 Million Cash Infusion From Bayer For Hemophilia Program

Jul 02 2008

Repligen Seeks Preliminary Injunction Against Bristol’s RA Therapy Orencia

Jan 06 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window